{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T22:41:57Z","timestamp":1760395317041,"version":"build-2065373602"},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T00:00:00Z","timestamp":1438128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>\n<jats:table-wrap position=\"anchor\">\n\n<jats:table frame=\"hsides\">\n<jats:col\/>\n<jats:tbody>\n<jats:tr>\n<jats:td>Preclinical Research<\/jats:td>\n<\/jats:tr>\n<\/jats:tbody>\n<\/jats:table>\n<\/jats:table-wrap><\/jats:p><jats:p>The mechanisms mediating canine pruritus are poorly understood with few models due to limited methods for inducing pruritus in dogs. Chloroquine (CQ) is a widely used antimalarial drug that causes pruritus in humans and mice. We have developed a canine model of pruritus where CQ reliably induced pruritus in all dogs tested following intravenous administration. This model is presently being used to test antipruritic activity of drug candidate molecules. This publication has been validated in a blinded cross\u2010over study in eight beagle dogs using the reference standards, oclacitinib and prednisolone, and has been used to test a new compound, norketotifen. All compounds reduced CQ\u2010induced pruritus in the dog. The sensitivity of the model was demonstrated using norketotifen, which at three dose levels, dose\u2010dependently, inhibited scratching events compared with placebo. Drug Dev Res 76 : 246\u2010250, 2015. \u00a9 2015 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ddr.21261","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T01:49:35Z","timestamp":1438134575000},"page":"246-250","source":"Crossref","is-referenced-by-count":6,"title":["Characterization and Validation of a Canine Pruritic Model"],"prefix":"10.1002","volume":"76","author":[{"given":"Gunnar A.K.","family":"Aberg","sequence":"first","affiliation":[{"name":"Bridge Pharma Inc. 902 Contento Street Sarasota FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Arulnesan","sequence":"additional","affiliation":[{"name":"Nucro\u2010Technics, Department of Toxicology 2000 Ellesmere Road Scarborough ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon T.","family":"Bolger","sequence":"additional","affiliation":[{"name":"Nucro\u2010Technics, Department of Toxicology 2000 Ellesmere Road Scarborough ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent B.","family":"Ciofalo","sequence":"additional","affiliation":[{"name":"Bridge Pharma Inc. 902 Contento Street Sarasota FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kresimir","family":"Pucaj","sequence":"additional","affiliation":[{"name":"CroToxPath Consulting Inc. 1920 Ellesmere Rd Scarborough ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.12265"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2008.00716.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.10.048"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12025"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac60052a025"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1084"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2015.04.016"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvp.12101"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2012.01098.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.11.034"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-012-0080-2"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12158"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(91)90017-R"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2009.00854.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2789"},{"key":"e_1_2_6_17_1","unstructured":"YaoY BilsboroughJ.2011. Methods of treating pain using antagonists of IL\u201031 IL\u201031RA and\/or OSMRB. US Patent 7 943 132 B2."},{"key":"e_1_2_6_18_1","first-page":"67","article-title":"Pruritus in certain internal diseases","volume":"11","author":"Yonova D.","year":"2007","journal-title":"Hippokratia"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio821"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-4-61"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fddr.21261","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T22:00:59Z","timestamp":1760392859000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.21261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,29]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1002\/ddr.21261"],"URL":"https:\/\/doi.org\/10.1002\/ddr.21261","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"type":"print","value":"0272-4391"},{"type":"electronic","value":"1098-2299"}],"subject":[],"published":{"date-parts":[[2015,7,29]]}}}